Exome Asset Management

Exome Asset Management is a culturally diverse, innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, including pharmaceuticals, biotechnology, healthcare services, and medical devices. Exome employs sound investment strategies and a philosophy developed by Samuel D. Isaly, who has spent the majority of his 45-year career focused on both developed and emerging markets healthcare

Minority owned,emerging markets healthcare,diversity and inclusion,healthcare investing,impact investor,biotech investing,asset management,hedge fund,financial services,and emerging markets

Exome asset management operates in the Investment management industry.

Exome asset management's revenue is 11m - 100m

Exome asset management has 11 - 50 employees.